Illimis Therapeutics’ Series B round was led by Korean venture capital firm DSC Investment. Seoul-based Illimis Therapeutics has raised 58 billion won ($42 million) to fund its research into ...

Britain launched a life sciences sector plan on Wednesday to a mixed response from the pharmaceutical industry, which welcomed proposals to boost R&D but warned it would fail to keep firms competitive ...

Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in digital services and consulting, has announced a ...

Waters and BD will merge biosciences and diagnostics in a $17.5B deal via Reverse Morris Trust, creating a life sciences ...

Johannes Fruehauf left Germany for the United States more than 20 years ago to propel his scientific career. But amid ...

Life sciences research is ready to embrace cloud-native solutions that provide platforms tailored to support scientific ...

In order to advance science-based conservation of the Asian elephant (elephas maximus), the Karnataka Forest Department and ...

D bioprinting uses living cells as "ink" to create functional tissues. Discover how this technology is transforming medicine ...

Artificial intelligence continues to revolutionize virtually every facet of modern life, and healthcare is no exception. But ...

Waters plans to combine with the Biosciences & Diagnostic Solutions business of BD (Becton, Dickinson & Co.), the companies said, in a $17.5 billion deal that would be the year’s largest within life ...

Lab equipment maker Waters Corp on Monday said it will buy a bioscience and diagnostics unit spun off from medtech provider ...